June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Intense Pulsed Light as a Treatment for Dry-eye Disease due to Meibomian Gland Dysfunction
Author Affiliations & Notes
  • Rolando Toyos
    Toyos Clinic, Memphis, TN
  • Footnotes
    Commercial Relationships Rolando Toyos, Dermamed (C), Bausch & Lomb (C), Alcon (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 966. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rolando Toyos; Intense Pulsed Light as a Treatment for Dry-eye Disease due to Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2013;54(15):966.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To determine the clinical benefits of intense-pulsed-light therapy for the treatment of dry-eye disease due to meibomian gland dysfunction.

Methods: A retrospective non-comparative interventional case series was conducted of 91 patients presenting with severe dry eye syndrome (eligibility tear breakup time less than 10 seconds or patient referral). Treatment included intense-pulsed-light therapy and gland expression at a single outpatient clinic over a 30-month study period beginning May 2009. Pre/post tear breakup time data were available for a subset of 78 patients. For all patients, a specially-developed technique for the treatment of dry eye syndrome was applied as a series of monthly treatments until adequate improvement in dry eye syndrome symptoms by physician-judgment or patient-discontinuation.

Results: Primary outcomes included change in tear breakup time by Oculus Non-Invasive or by Standard Invasive using Flourescein methods, self-reported patient satisfaction, and adverse events. Physician-judged improvement in dry-eye tear breakup time were found for 68 of 78 (87%) of patients with 7 treatment visits and 4 maintenance visits on average (medians). 93% of patients reported post-treatment satisfaction with dry eye syndrome symptoms. Adverse events, most typically redness or swelling, were found for 13% of patients. No serious adverse events were found.

Conclusions: While preliminary, study results of intense-pulsed-light therapy treatment for dry eye syndrome due to meibomian gland dysfunction are promising. A multi-site clinical trial with a larger sample, treatment comparison groups and randomized controlled trials is currently underway.

Keywords: 482 cornea: epithelium • 526 eyelid  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.